Donepezil vs Durvalumab
Donepezil vs Durvalumab: Overview
This comparison examines the pharmacological differences between Donepezil and Durvalumab.
Mechanism of Action
Donepezil: Reversible acetylcholinesterase inhibitor.
Durvalumab: Human IgG1 kappa anti-PD-L1 monoclonal antibody blocking PD-L1 binding to PD-1 and CD80.
Pharmacokinetics
Half-life: Donepezil — 70 hours; Durvalumab — 17 days.
Chemical Properties
Molecular Formula: Donepezil — C24H29NO3.
Molecular Weight: Donepezil — 379.4920 g/mol.
Type: Donepezil — Small molecule; Durvalumab — Antibody.